CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 191 enrolled
Drug / intervention
Placebo +3 moredrug
Likely dose
Sibutramine/Orlistat 15 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00829283
NCT00829283N/ACompleted
CompareCT.gov

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

Yale University·interventional·Posted Jan 27, 2009·Updated Apr 3, 2020

In Brief

A clinical study evaluating Behavioral Weight Loss, Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy, and 2 other interventions for Obesity and Binge Eating. Completed, enrolled 191 participants across 1 site.

Detailed Summary

This controlled study will test the effectiveness of a stepped-care approach to a standard behavioral weight loss treatment for obese patients with Binge Eating Disorder (BED). The major question is whether the stepped-care approach, which begins with behavioral weight loss and then follows a decision tree for additional interventions based on early treatment response is superior to standard behavioral treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Binge Eating
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 27, 2009
Enrollment StartNov 1, 2008
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 17.4 years ago

Interventions

Behavioral Weight Lossbehavioral

weekly individual sessions for 6 months

Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapybehavioral

weekly BWL sessions for 4 weeks and 6-8 CBT sessions for 5 months

Placebodrug

One pill daily

Sibutramine/Orlistatdrug

Sibutramine 15 mg daily or Orlistat 120mg TID